Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Ischemic Heart Disease

Free Subscription Articles published in JAMA Retrieve available abstracts of 90 articles: HTML format Text format

Single Articles

March 2010
1. FOWKES FG , Price JF, Stewart MC, Butcher I, et al
   Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.
   JAMA. 2010;303:841-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. PLETCHER MJ , Tice JA, Pignone M
   Modeling cardiovascular disease prevention.
   JAMA. 2010;303:835.
   PubMed     Text format     Related articles   
   
   
   
3. FAYSSOIL A
   Aldosterone antagonists in patients with heart failure.
   JAMA. 2010;303:833.
   PubMed     Text format     Related articles   
   
   
   February 2010
4. BREET NJ , van Werkum JW, Bouman HJ, Kelder JC, et al
   Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
   JAMA. 2010;303:754-62.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. STRANDBERG TE
   Cardiovascular disease, hypertension, and risk of hip fracture.
   JAMA. 2010;303:731.
   PubMed     Text format     Related articles   
   
   
   
6. PATEL A , Neal B, Chalmers J
   Event rates in trials of patients with type 2 diabetes.
   JAMA. 2010;303:732.
   PubMed     Text format     Related articles   
   
   
   
7. PREISS D , Sattar N, McMurray JJ
   Event rates in trials of patients with type 2 diabetes.
   JAMA. 2010;303:732-3.
   PubMed     Text format     Related articles   
   
   
   
8. PAYNTER NP , Chasman DI, Pare G, Buring JE, et al
   Association between a literature-based genetic risk score and cardiovascular events in women.
   JAMA. 2010;303:631-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. HEMMELGARN BR , Manns BJ, Lloyd A, James MT, et al
   Relation between kidney function, proteinuria, and adverse outcomes.
   JAMA. 2010;303:423-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
10. FARZANEH-FAR R , Lin J, Epel ES, Harris WS, et al
    Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease.
    JAMA. 2010;303:250-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. BLUMBERG MS
    Hospital mortality in acute myocardial infarction.
    JAMA. 2010;303:133.
    PubMed     Text format     Related articles   
    
    
    
12. DOREN M
    Hospital mortality in acute myocardial infarction.
    JAMA. 2010;303:132-3.
    PubMed     Text format     Related articles   
    
    
    
13. RIEZEBOS RK , Laarman GJ
    Intervention timing and acute coronary syndromes.
    JAMA. 2010;303:131-2.
    PubMed     Text format     Related articles   
    
    
    
14. TORPY JM , Burke AE, Glass RM
    JAMA patient page. Acute coronary syndromes.
    JAMA. 2010;303:90.
    PubMed     Text format     Related articles   
    
    
    
15. EDWARDS JL
    Hormonal therapy for prostate cancer in men with heart disease.
    JAMA. 2010;303:32.
    PubMed     Text format     Related articles   
    
    
    December 2009
16. DHRUVA SS , Bero LA, Redberg RF
    Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices.
    JAMA. 2009;302:2679-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. TSAI TT , Maddox TM, Roe MT, Dai D, et al
    Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention.
    JAMA. 2009;302:2458-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. TORPY JM , Burke AE, Glass RM
    JAMA patient page. Coronary heart disease risk factors.
    JAMA. 2009;302:2388.
    PubMed     Text format     Related articles   
    
    
    
19. WILSON PW
    Challenges to improve coronary heart disease risk assessment.
    JAMA. 2009;302:2369-70.
    PubMed     Text format     Related articles   
    
    
    
20. TZOULAKI I , Liberopoulos G, Ioannidis JP
    Assessment of claims of improved prediction beyond the Framingham risk score.
    JAMA. 2009;302:2345-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. MIRAKAJ V , Thix CA, Rosenberger P
    Intraoperative diagnosis and management of patent foramen ovale.
    JAMA. 2009;302:2317.
    PubMed     Text format     Related articles   
    
    
    November 2009
22. KUMBHANI DJ , Cannon CP, Fonarow GC, Liang L, et al
    Association of Hospital Primary Angioplasty Volume in ST-Segment Elevation Myocardial Infarction With Quality and Outcomes.
    JAMA. 2009;302:2207-2213.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. HINGORANI AD , Psaty BM
    Primary Prevention of Cardiovascular Disease: Time to Get More or Less Personal?
    JAMA. 2009;302:2144-2145.
    PubMed     Text format     Related articles   
    
    
    
24. COOK NR
    Biomarkers for Prediction of Cardiovascular Events.
    JAMA. 2009;302:2089.
    PubMed     Text format     Related articles   
    
    
    
25. ROSENSTEIN RS , Parra D
    Biomarkers for Prediction of Cardiovascular Events.
    JAMA. 2009;302:2089-2090.
    PubMed     Text format     Related articles   
    
    
    October 2009
26. DE JAGER DJ , Grootendorst DC, Jager KJ, van Dijk PC, et al
    Cardiovascular and noncardiovascular mortality among patients starting dialysis.
    JAMA. 2009;302:1782-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. CARNEY RM , Freedland KE, Rubin EH, Rich MW, et al
    Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
    JAMA. 2009;302:1651-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. JONES SR , Blumenthal RS
    Lipoprotein(a) Measurement and Determining Risk of Myocardial Infarction.
    JAMA. 2009;302:1645.
    PubMed     Text format     Related articles   
    
    
    
29. SENNERBY U , Melhus H, Gedeborg R, Byberg L, et al
    Cardiovascular diseases and risk of hip fracture.
    JAMA. 2009;302:1666-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. PSATY BM , Prentice RL
    Variation in event rates in trials of patients with type 2 diabetes.
    JAMA. 2009;302:1698-700.
    PubMed     Text format     Related articles   
    
    
    September 2009
31. COPLAN N
    Assessing cardiovascular risk factors in National Football League players.
    JAMA. 2009;302:1166.
    PubMed     Text format     Related articles   
    
    
    
32. TAKAGI H , Umemoto T
    Aspirin for prevention of stroke and cardiovascular events among patients with peripheral artery disease.
    JAMA. 2009;302:1165.
    PubMed     Text format     Related articles   
    
    
    
33. MONTALESCOT G , Cayla G, Collet JP, Elhadad S, et al
    Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial.
    JAMA. 2009;302:947-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. PALMERINI T , De Servi S, Branzi A
    Prognostic importance of ventricular arrhythmia in patients treated with percutaneous coronary intervention.
    JAMA. 2009;302:943-4.
    PubMed     Text format     Related articles   
    
    
    August 2009
35. NANDA A , Chen MH, Braccioforte MH, Moran BJ, et al
    Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.
    JAMA. 2009;302:866-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. BERGER JS , Elliott L, Gallup D, Roe M, et al
    Sex differences in mortality following acute coronary syndromes.
    JAMA. 2009;302:874-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. BHATT DL
    Tailoring antiplatelet therapy based on pharmacogenomics: how well do the data fit?
    JAMA. 2009;302:896-7.
    PubMed     Text format     Related articles   
    
    
    
38. SHULDINER AR , O'Connell JR, Bliden KP, Gandhi A, et al
    Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.
    JAMA. 2009;302:849-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. KRUMHOLZ HM , Wang Y, Chen J, Drye EE, et al
    Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006.
    JAMA. 2009;302:767-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. VIDOVICH MI
    Screening for asymptomatic coronary artery disease in patients with type 2 diabetes.
    JAMA. 2009;302:736.
    PubMed     Text format     Related articles   
    
    
    
41. CHIKAMORI T
    Screening for asymptomatic coronary artery disease in patients with type 2 diabetes.
    JAMA. 2009;302:735.
    PubMed     Text format     Related articles   
    
    
    
42. VINIK AI , Maser RE
    Screening for asymptomatic coronary artery disease in patients with type 2 diabetes.
    JAMA. 2009;302:735-6.
    PubMed     Text format     Related articles   
    
    
    
43. SEIDEN SW
    Evaluating patients with persistent chest pain and no obstructive coronary artery disease.
    JAMA. 2009;302:622.
    PubMed     Text format     Related articles   
    
    
    
44. BELTRAME JF , Ganz P
    Evaluating patients with persistent chest pain and no obstructive coronary artery disease.
    JAMA. 2009;302:622-3.
    PubMed     Text format     Related articles   
    
    
    
45. COHEN BE , Marmar C, Ren L, Bertenthal D, et al
    Association of cardiovascular risk factors with mental health diagnoses in Iraq and Afghanistan war veterans using VA health care.
    JAMA. 2009;302:489-92.
    PubMed     Text format     Related articles   
    
    
    July 2009
46. ERQOU S , Kaptoge S, Perry PL, Di Angelantonio E, et al
    Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
    JAMA. 2009;302:412-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. ROGER VL
    Lifestyle and cardiovascular health: individual and societal choices.
    JAMA. 2009;302:437-9.
    PubMed     Text format     Related articles   
    
    
    
48. ELLIOTT P , Chambers JC, Zhang W, Clarke R, et al
    Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.
    JAMA. 2009;302:37-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. SHAH SH , de Lemos JA
    Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment.
    JAMA. 2009;302:92-3.
    PubMed     Text format     Related articles   
    
    
    
50. MELANDER O , Newton-Cheh C, Almgren P, Hedblad B, et al
    Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.
    JAMA. 2009;302:49-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. MATTSON-DICECCA AA , Reynolds E
    Update: A 59-year-old man considering implantation of a cardiac defibrillator.
    JAMA. 2009;302:81.
    PubMed     Text format     Related articles   
    
    
    
52. DAKIK HA , Barada K
    Adverse outcomes associated with use of proton pump inhibitors and clopidogrel.
    JAMA. 2009;302:30.
    PubMed     Text format     Related articles   
    
    
    
53. HAYES S
    Adverse outcomes associated with use of proton pump inhibitors and clopidogrel.
    JAMA. 2009;302:30-1.
    PubMed     Text format     Related articles   
    
    
    
54. CHAE YK , Kim J
    Adverse outcomes associated with use of proton pump inhibitors and clopidogrel.
    JAMA. 2009;302:29.
    PubMed     Text format     Related articles   
    
    
    
55. SCHNEIDER-LINDNER V , Filion KB, Brophy JM
    Adverse outcomes associated with use of proton pump inhibitors and clopidogrel.
    JAMA. 2009;302:29-30.
    PubMed     Text format     Related articles   
    
    
    June 2009
56. HULLEY S , Grady D
    Postmenopausal hormone treatment.
    JAMA. 2009;301:2493-5.
    PubMed     Text format     Related articles   
    
    
    
57. WATERS DJ
    A piece of my mind. Heart, attacked.
    JAMA. 2009;301:2423.
    PubMed     Text format     Related articles   
    
    
    
58. KAMSTRUP PR , Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG, et al
    Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
    JAMA. 2009;301:2331-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. THANASSOULIS G , O'Donnell CJ
    Mendelian randomization: nature's randomized trial in the post-genome era.
    JAMA. 2009;301:2386-8.
    PubMed     Text format     Related articles   
    
    
    
60. RAFF GL , Chinnaiyan KM, Share DA, Goraya TY, et al
    Radiation dose from cardiac computed tomography before and after implementation of radiation dose-reduction techniques.
    JAMA. 2009;301:2340-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. LEUNISSEN RW , Kerkhof GF, Stijnen T, Hokken-Koelega A, et al
    Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood.
    JAMA. 2009;301:2234-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
62. TUCKER AM , Vogel RA, Lincoln AE, Dunn RE, et al
    Prevalence of cardiovascular disease risk factors among National Football League players.
    JAMA. 2009;301:2111-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. KODAMA S , Saito K, Tanaka S, Maki M, et al
    Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.
    JAMA. 2009;301:2024-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. VAN RAMSHORST J , Bax JJ, Beeres SL, Dibbets-Schneider P, et al
    Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
    JAMA. 2009;301:1997-2004.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. MITKA M
    Researchers argue imaging has role in assessing cardiovascular disease risk.
    JAMA. 2009;301:1973-4.
    PubMed     Text format     Related articles   
    
    
    
66. BERGER JS , Krantz MJ, Kittelson JM, Hiatt WR, et al
    Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
    JAMA. 2009;301:1909-19.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. VICHAYAVILAS P , Kelly C
    Relationship between sleep duration and incident coronary artery calcification.
    JAMA. 2009;301:1879.
    PubMed     Text format     Related articles   
    
    
    
68. MEHTA RH , Starr AZ, Lopes RD, Hochman JS, et al
    Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.
    JAMA. 2009;301:1779-89.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. RENNIE D , Chalmers I
    Assessing authority.
    JAMA. 2009;301:1819-21.
    PubMed     Text format     Related articles   
    
    
    April 2009
70. REIFFEL JA
    Equivalence of generic and brand-name drugs for cardiovascular disease.
    JAMA. 2009;301:1655.
    PubMed     Text format     Related articles   
    
    
    
71. CARTER BL
    Equivalence of generic and brand-name drugs for cardiovascular disease.
    JAMA. 2009;301:1654.
    PubMed     Text format     Related articles   
    
    
    
72. ZEMA MJ
    Equivalence of generic and brand-name drugs for cardiovascular disease.
    JAMA. 2009;301:1654-5.
    PubMed     Text format     Related articles   
    
    
    
73. KOSIBOROD M , Inzucchi SE, Goyal A, Krumholz HM, et al
    Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction.
    JAMA. 2009;301:1556-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. YOUNG LH , Wackers FJ, Chyun DA, Davey JA, et al
    Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.
    JAMA. 2009;301:1547-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. CHELLAPPA P , Ramaraj R
    Depression, homocysteine concentration, and cardiovascular events.
    JAMA. 2009;301:1541-2.
    PubMed     Text format     Related articles   
    
    
    
76. PHAN A , Shufelt C, Merz CN
    Persistent chest pain and no obstructive coronary artery disease.
    JAMA. 2009;301:1468-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. HILDRETH CJ , Burke AE, Glass RM
    JAMA patient page. Chest pain.
    JAMA. 2009;301:1498.
    PubMed     Text format     Related articles   
    
    
    
78. PADAYATTY SJ , Levine M
    Antioxidant supplements and cardiovascular disease in men.
    JAMA. 2009;301:1336.
    PubMed     Text format     Related articles   
    
    
    
79. VIOLI F , Cangemi R
    Antioxidant supplements and cardiovascular disease in men.
    JAMA. 2009;301:1335.
    PubMed     Text format     Related articles   
    
    
    
80. EVANS JM
    Antioxidant supplements and cardiovascular disease in men.
    JAMA. 2009;301:1335-6.
    PubMed     Text format     Related articles   
    
    
    March 2009
81. KESTEN S , Leimer I, Jara M
    Risk of major adverse cardiovascular events with inhaled anticholinergics in patients with chronic obstructive pulmonary disease.
    JAMA. 2009;301:1224.
    PubMed     Text format     Related articles   
    
    
    
82. HODGIN KE , Maloney JP
    Risk of major adverse cardiovascular events with inhaled anticholinergics in patients with chronic obstructive pulmonary disease.
    JAMA. 2009;301:1224.
    PubMed     Text format     Related articles   
    
    
    
83. OBA Y
    Risk of major adverse cardiovascular events with inhaled anticholinergics in patients with chronic obstructive pulmonary disease.
    JAMA. 2009;301:1223.
    PubMed     Text format     Related articles   
    
    
    
84. COVELLI HD
    Risk of major adverse cardiovascular events with inhaled anticholinergics in patients with chronic obstructive pulmonary disease.
    JAMA. 2009;301:1223.
    PubMed     Text format     Related articles   
    
    
    
85. ZHAO Z , Guan H, Shang L
    Surveillance of sudden death after myocardial infarction.
    JAMA. 2009;301:1123.
    PubMed     Text format     Related articles   
    
    
    
86. KOSTIS WJ , Schulman SP
    Documenting ischemia prior to elective percutaneous coronary intervention.
    JAMA. 2009;301:1018.
    PubMed     Text format     Related articles   
    
    
    
87. NOON GP
    Evolution of surgical treatment of coronary artery occlusive disease.
    JAMA. 2009;301:970-1.
    PubMed     Text format     Related articles   
    
    
    
88. HO PM , Maddox TM, Wang L, Fihn SD, et al
    Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.
    JAMA. 2009;301:937-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
89. NDREPEPA G , Kastrati A, Mehilli J, Antoniucci D, et al
    Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms.
    JAMA. 2009;301:487-8.
    PubMed     Text format     Related articles   
    
    
    January 2009
90. STRANDBERG TE , Pitkala KH, Tilvis RS
    Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease.
    JAMA. 2009;301:380-2.
    PubMed     Text format     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: